METHAQUALONE

Important information regarding METHAQUALONE drug use


Glutethimide (Doriden) was introduced in 1954 and methaqualone (Quaalude, Sopor) in 1965 a safe barbiturate substitutes. Experience showed, however, that their addiction liability and the severity of withdrawal symptoms were similar to those of barbiturates.

By 1972, "luding out," taking methaqualone with wine, was a popular college pastime. Excessive use leads to tolerance, dependence and withdrawal symptoms similar to those of barbiturates. Overdose by glutethimide and methaqualone is more difficult to treat than barbiturate overdose, and deaths have frequently occurred. In the United States, the marketing of methaqualone pharmaceutical products stopped in 1984 and methaqualone was transferred to Schedule I of the CSA. In 1991, glutethimide was transferred into Schedule II in response to an upsurge in the prevalence of diversion, abuse and overdose deaths.

[Abstracted from D.E.A. website q.v.]

METHAQUALONE
Effects
Sedative hypnotic..... with a unique specificity in regard to sexual disinhibition!
Incidence of Abuse
Probably rare.
Forms and Street Names
Methaqualone, under the trade name "Quaalude," was a widely prescribed sedative hypnotic in the 1970's. Because of its toxicity and the development of the much safer benzodiazepines, it was removed from the maket in 1983 and is now classified as a Schedule I drug! [no legal medical use in the U.S.]
Length of time detectable after user
2 - 4 days.
Metabolite Actually sought in urine
Methaqualone
Confounding drugs (or factors):
None known
Screening Cut-off:
300 ng/ml
Confirmation GC/MS Cut-of
300 ng/ml
Facts for Verifying M.R.O
Verification is straightforward because Methaqualone is now Schedule I. Employers, however, deserve to be told that including Methaqualone in test panels has long been felt to be NOT ECONOMICALLY JUSTIFIABLE!






Home
Services
Why Test
Drugs of Abuse
Employer References
MRO Resources
Collection Services
Resources
Rapid Drug Test
Online Training
News Archive
About Us

CONTACT US

Request Information »

Nationwide Medical Review

7168 Graham Road, Suite 150
Indianapolis, IN 46250

Phone 317-547-8620
Toll Free 888-265-6362
Fax 317-568-0849
info@drugfreeworkplace.com

© Copyright 1999 - 2012 Nationwide Medical Review. Website Developed by Elixir Marketing, LLC

Industry News

10-21-2011 Nationwide Medical Review offers NEW! DOT Collector Training Course:

08/16/2010 DOT Issues Final Rule amending certain provisions of its drug testing procedures.

August 31 - Mandated Direct Observation Collection (Return-to-Duty and Follow-up)

 DOT Direct Observation Procedure Sheet 

Self Assessment Quiz!
(Updated 8/09)

For More News
See our Archive